Skip to content
lifestyle.lincolnlabs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NOVAVAX, INC
Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe
October 29, 2026
Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026
October 29, 2026
Novavax to Participate in September Investor Conferences
September 2, 2026
Novavax’s Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
August 28, 2026
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
August 6, 2026
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026